Skip to main content

Table 6 HCC recurrence rate and time after HCC intervention in group I

From: Impact of treating chronic hepatitis C infection with direct-acting antivirals on the risk of hepatocellular carcinoma recurrence

 NumberPercent
HCC recurrence
 No3162.0
 Yes1938.0
Rec time after the start of DAAs (months) (n = 19)
 Min.–Max.5.0–18.0
 Mean ± SD9.47 ± 4.14
 Median8.0